The Oncology Insights Podcast - Dr. Thomas Marron: Immunotherapy Frontiers | Ep. 2
Aug 18, 2025In this episode of The Oncology Insights Podcast, Dr. Thomas Marron, Director of the Early Phase Trials Unit at Mount Sinai, explains how immunotherapy has reshaped cancer treatment. He discusses checkpoint inhibitors, cancer vaccines, cellular therapies, and the challenges of early-onset cancers. Learn how inflammation and aging impact immune response and what innovations are on the horizon. Listen now on all major platforms!
What will you learn:
- Checkpoint inhibitor evolution
- Cancer vaccine development
- Role of inflammation
- CAR-T therapy limits
- Immuno-prevention potential
Meet the guest:
Dr. Thomas Marron is Director of the Early Phase Trials Unit at Mount Sinai and a Professor of Medicine, Hematology, and Immunotherapy. With both an MD and PhD in Immunology, his research focuses on novel cancer immunotherapies and personalized vaccine strategies. He leads clinical trials that explore immune mechanisms and tumor biology in solid tumors.
Connect with our guest on Social Media: LinkedIn
Liked this one? Don’t stop now. Here’s what we think you’ll love!